Log In
BCIQ
Print this Print this
 

Epicyn HydroGel

  Manage Alerts
Collapse Summary General Information
Company Sonoma Pharmaceuticals Inc.
DescriptionShelf-stable hypochlorous acid formulation based on the Microcyn Technology platform.
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Dermatology (unspecified)
Indication DetailsTreat symptoms associated with associated with various types of dermatoses (under supervision of physician), to treat the pain of first- and second-degree burns and to treat dry waxy skin
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$0.5M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/21/2011

Undisclosed

$0.5M

0

Get a free BioCentury trial today